As of May 26
| -0.0315 / -8.96%|
The 1 analysts offering 12-month price forecasts for Remedent Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +368.75% increase from the last price of 0.32.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.